Get started
Author

Saihitha Veerapaneni

Association of differential expression of immunoregulatory molecules and presence of targetable mutations may inform rational design of clinical trials
2022 · C.W. Szeto, R. Kurzrock, et al. · ESMO Open · 17
3D-QSAR and SVM Prediction of BRAF-V600E and HIV Integrase Inhibitors: A Comparative Study and Characterization of Performance with a New Expected Prediction Performance Metric
2016 · Leonard Wesley, Saihitha Veerapaneni, et al. · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · 8
PDF
Abstract 2224: Validated differential expression of immunoregulatory molecules that coincide with targetable mutations may provide novel insights into strategic trial design for therapeutics
2020 · Jacob J. Adashek, Christopher W. Szeto, et al. · Cancer Research · 2
Effect of chemokine signaling signatures on resolving discrepancy between TMB and checkpoint expression.
2020 · Christopher Szeto, Saihitha Veerapaneni, et al. · Journal of Clinical Oncology
Abstract B093: 50 gene breast cancer (BC) RNA subtype classifier and colorectal cancer (CRC) CMS subtype classifier applied to 90 prostate cancer (PC) patients reveals distinct subtype differences
2019 · Jacob J Adashek, Sumanta K Pal, et al. · Molecular Cancer Therapeutics
Comprehensive profiling of immune landscape in gastrointestinal (GI) and head and neck (HN) cancers via computational deconvolution.
2019 · Christopher Szeto, Saihitha Veerapaneni, et al. · Journal of Clinical Oncology
Unique molecular features of the HIV-1 subtype C enhancer and core promoter and their influence on the viral gene expression
2013 · Anjali Verma, Pavithra Rajgopalan, et al. · Retrovirology
PDF
Works count: 7
Citation count: 27
H-index: 2
I10-index: 1
Year
Topic
Type